Non-Inferiority Trials

被引：0
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2011年 / 53卷 / 1355期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
[41]   A comparison of testing methods in non-inferiority clinical trials [J].
Park, Jieun ;
Lee, Jae Won .
COMMUNICATIONS FOR STATISTICAL APPLICATIONS AND METHODS, 2024, 31 (06) :613-625
[42]   Non-inferiority margins employed in clinical trials in Japan [J].
Gosho, M. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) :289-298
[43]   Bio-creep in non-inferiority clinical trials [J].
Everson-Stewart, Siobhan ;
Emerson, Scott S. .
STATISTICS IN MEDICINE, 2010, 29 (27) :2769-2780
[44]   Regulatory Scientific Advice on Non-Inferiority Drug Trials [J].
Wangge, Grace ;
Putzeist, Michelle ;
Knol, Mirjam J. ;
Klungel, Olaf H. ;
Gispen-De Wied, Christine C. ;
de Boer, Antonius ;
Hoes, Arno W. ;
Leufkens, Hubert G. ;
Mantel-Teeuwisse, Aukje K. .
PLOS ONE, 2013, 8 (09)
[45]   Issues on the selection of non-inferiority margin in clinical trials [J].
Hou Yan ;
Wu Xiao-yan ;
Li Kang .
CHINESE MEDICAL JOURNAL, 2009, 122 (04) :466-470
[46]   Non-inferiority trials: the "at least as good as" criterion. [J].
Laster, LL ;
Johnson, MF .
JOURNAL OF DENTAL RESEARCH, 2002, 81 :A219-A219
[47]   Issues on the selection of non-inferiority margin in clinical trials [J].
HOU Yan .
中华医学杂志（英文版）, 2009, (04) :466-470
[48]   Design and analysis of non-inferiority mortality trials in oncology [J].
Rothmann, M ;
Li, N ;
Chen, G ;
Chi, GYH ;
Temple, R ;
Tsou, HH .
STATISTICS IN MEDICINE, 2003, 22 (02) :239-264
[49]   Bayesian approach to non-inferiority trials for normal means [J].
Gamalo, M. Amper ;
Wu, Rui ;
Tiwari, Ram C. .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2016, 25 (01) :221-240
[50]   Non-inferiority and equivalence trials: Key methodological issues [J].
Herr, M. ;
Descatha, A. ;
Aegerter, P. .
REVUE DE MEDECINE INTERNE, 2018, 39 (05) :352-359
12345